{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "13",
                "@timestamp": "2023-07-13T20:47:09.000009-04:00",
                "@year": "2023",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Novartis Healthcare Pvt Ltd."},
                {
                    "xocs:funding-agency-matched-string": "Novartis Pharmaceuticals Corporation",
                    "xocs:funding-agency-acronym": "NPC",
                    "xocs:funding-agency": "Novartis Pharmaceuticals Corporation",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008272",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-04-13T12:40:35.321Z",
            "xocs:funding-text": "This study was funded by Novartis Pharmaceuticals Corporation. The authors express their sincere gratitude to the participating patients, their families, all of the study co-investigators, and research contributors. Medical writing support was funded by Novartis Pharmaceuticals Corporation and was provided by Varunkumar Pandey, Novartis Healthcare Pvt Ltd. (Hyderabad, India).",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60115402",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Yonsei Cancer Center"},
                                {"$": "Yonsei University College of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60115402",
                                    "@dptid": "122182845"
                                },
                                {"@afid": "60016728"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947302102-0d762c99ff993c96751d83c31d43acc9-1",
                            "ce:source-text": "Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea",
                            "@dptid": "122182845"
                        },
                        "author": [{
                            "ce:given-name": "Byoung Chul",
                            "preferred-name": {
                                "ce:given-name": "Byoung Chul",
                                "ce:initials": "B.C.",
                                "ce:surname": "Cho",
                                "ce:indexed-name": "Cho B.C."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-ee5ebf0dab8d05fa7b2b716555a1b68f-1",
                            "@seq": "1",
                            "ce:initials": "B.C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Cho",
                            "@auid": "57211677252",
                            "@orcid": "0000-0002-5562-270X",
                            "ce:indexed-name": "Cho B.C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60021119",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "Seoul National University Hospital"},
                                {"$": "Seoul National University College of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60021119",
                                    "@dptid": "113568198"
                                },
                                {"@afid": "60000656"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947302102-c7f90d6901a7d2ea148f83ec7103b55f-1",
                            "ce:source-text": "Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea",
                            "@dptid": "113568198"
                        },
                        "author": [{
                            "ce:given-name": "Dong-Wan",
                            "preferred-name": {
                                "ce:given-name": "Dong Wan",
                                "ce:initials": "D.W.",
                                "ce:surname": "Kim",
                                "ce:indexed-name": "Kim D.W."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-2c6b1b48cb622412bf6a0d2450f5bf51-1",
                            "@seq": "2",
                            "ce:initials": "D.-W.",
                            "@date-locked": "2023-05-05T05:40:20.491",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kim",
                            "@auid": "56189698600",
                            "ce:indexed-name": "Kim D.-W."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "India",
                            "@afid": "60070271",
                            "@country": "ind",
                            "city": "New Delhi",
                            "organization": [
                                {"$": "Medical Oncology"},
                                {"$": "Rajiv Gandhi Cancer Institute and Research Center"}
                            ],
                            "affiliation-id": {"@afid": "60070271"},
                            "@affiliation-instance-id": "OB2BibRecID-947302102-1354fa7fa042fa216296c4d4c625ee94-1",
                            "ce:source-text": "Medical Oncology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India"
                        },
                        "author": [{
                            "ce:given-name": "Ullas",
                            "preferred-name": {
                                "ce:given-name": "Ullas",
                                "ce:initials": "U.",
                                "ce:surname": "Batra",
                                "ce:indexed-name": "Batra U."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-5f218d6cc5627b8a41907406fdf24bc4-1",
                            "@seq": "3",
                            "ce:initials": "U.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Batra",
                            "@auid": "15924728800",
                            "ce:indexed-name": "Batra U."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60020857",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Division of Hematology-Oncology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Samsung Medical Center"},
                                {"$": "Sungkyunkwan University School of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60020857",
                                    "@dptid": "108299464"
                                },
                                {"@afid": "60016329"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947302102-c084401071dad0941cb071efd7d36c18-1",
                            "ce:source-text": "Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea",
                            "@dptid": "108299464"
                        },
                        "author": [{
                            "ce:given-name": "Keunchil",
                            "preferred-name": {
                                "ce:given-name": "Keunchil",
                                "ce:initials": "K.",
                                "ce:surname": "Park",
                                "ce:indexed-name": "Park K."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-4aad82931402d7562b0fc16d1d143c52-1",
                            "@seq": "4",
                            "ce:initials": "K.",
                            "@date-locked": "2023-05-26T12:50:58.940",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Park",
                            "@auid": "7408064384",
                            "ce:indexed-name": "Park K."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60068691",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Department of Oncology"},
                                {"$": "Asan Medical Center"},
                                {"$": "University of Ulsan College of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60068691",
                                    "@dptid": "113759348"
                                },
                                {"@afid": "60006240"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947302102-01f6de679536f9ea7d34bb6d17b83da1-1",
                            "ce:source-text": "Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",
                            "@dptid": "113759348"
                        },
                        "author": [{
                            "ce:given-name": "Sang-We",
                            "preferred-name": {
                                "ce:given-name": "Sang We",
                                "ce:initials": "S.W.",
                                "ce:surname": "Kim",
                                "ce:indexed-name": "Kim S.W."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-026365e3711752bf96373f2106134601-1",
                            "@seq": "5",
                            "ce:initials": "S.-W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Kim",
                            "@auid": "57939462700",
                            "ce:indexed-name": "Kim S.-W."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60020351",
                            "@country": "twn",
                            "city": "Taoyuan",
                            "organization": [
                                {"$": "Chang Gung Memorial Hospital"},
                                {"$": "Chang Gung University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60020351"},
                                {"@afid": "60031913"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947302102-3d43f918cbf2c29dd50e736354dc0747-1",
                            "ce:source-text": "Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan"
                        },
                        "author": [{
                            "ce:given-name": "Cheng-Ta",
                            "preferred-name": {
                                "ce:given-name": "Cheng Ta",
                                "ce:initials": "C.T.",
                                "ce:surname": "Yang",
                                "ce:indexed-name": "Yang C.T."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-ffc1ddb932c8d9c019a62d1830677892-1",
                            "@seq": "6",
                            "ce:initials": "C.-T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Yang",
                            "@auid": "8201458000",
                            "ce:indexed-name": "Yang C.-T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60090650",
                            "@country": "mys",
                            "city": "Kuching",
                            "organization": {"$": "Hospital Umum Sarawak"},
                            "affiliation-id": {"@afid": "60090650"},
                            "@affiliation-instance-id": "OB2BibRecID-947302102-4793e3ced23b9b8813ed244adbc1bde5-1",
                            "ce:source-text": "Hospital Umum Sarawak, Kuching, Malaysia"
                        },
                        "author": [{
                            "ce:given-name": "Pei-Jye",
                            "preferred-name": {
                                "ce:given-name": "Pei Jye",
                                "ce:initials": "P.J.",
                                "ce:surname": "Voon",
                                "ce:indexed-name": "Voon P.J."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-63c169898e4de5923c93c459d9cf4f46-1",
                            "@seq": "7",
                            "ce:initials": "P.-J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Voon",
                            "@auid": "50462645100",
                            "ce:indexed-name": "Voon P.-J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Chulalongkorn University"},
                                {"$": "The King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60022183"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947302102-a89a966336bf2ccdd8494c8e6b1a6369-1",
                            "ce:source-text": "Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Virote",
                            "preferred-name": {
                                "ce:given-name": "Virote",
                                "ce:initials": "V.",
                                "ce:surname": "Sriuranpong",
                                "ce:indexed-name": "Sriuranpong V."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-1e600bda6a1d180926396fce06016f98-1",
                            "@seq": "8",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sriuranpong",
                            "@auid": "6603599644",
                            "ce:indexed-name": "Sriuranpong V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "India",
                            "@afid": "60003789",
                            "@country": "ind",
                            "city": "Bengaluru",
                            "organization": [
                                {"$": "HCG Curie Center of Oncology"},
                                {"$": "Kidwai Memorial Institute of Oncology"}
                            ],
                            "affiliation-id": {"@afid": "60003789"},
                            "@affiliation-instance-id": "OB2BibRecID-947302102-8cc187ee5ee1c4b6026ab60782577f90-1",
                            "ce:source-text": "HCG Curie Center of Oncology and Kidwai Memorial Institute of Oncology, Bengaluru, India"
                        },
                        "author": [{
                            "ce:given-name": "K. Govind",
                            "preferred-name": {
                                "ce:given-name": "K. Govind",
                                "ce:initials": "K.G.",
                                "ce:surname": "Babu",
                                "ce:indexed-name": "Babu K.G."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-9fd4768acc419249b4b748c2cb86149c-1",
                            "@seq": "9",
                            "ce:initials": "K.G.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Babu",
                            "@auid": "7102427411",
                            "ce:indexed-name": "Babu K.G."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Switzerland",
                            "@afid": "60009968",
                            "@country": "che",
                            "city": "Basel",
                            "organization": {"$": "Novartis Pharma AG"},
                            "affiliation-id": {"@afid": "60009968"},
                            "@affiliation-instance-id": "OB2BibRecID-947302102-15bde9d7aa829698edbd6fbd98cd5a16-1",
                            "ce:source-text": "Novartis Pharma AG, Basel, Switzerland"
                        },
                        "author": [
                            {
                                "ce:given-name": "Khalid",
                                "preferred-name": {
                                    "ce:given-name": "Khalid",
                                    "ce:initials": "K.",
                                    "ce:surname": "Amin",
                                    "ce:indexed-name": "Amin K."
                                },
                                "@author-instance-id": "OB2BibRecID-947302102-1d509ce89b0277a521d8721ec9db4db9-1",
                                "@seq": "10",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Amin",
                                "@auid": "58067491900",
                                "ce:indexed-name": "Amin K."
                            },
                            {
                                "ce:given-name": "Yingbo",
                                "preferred-name": {
                                    "ce:given-name": "Yingbo",
                                    "ce:initials": "Y.",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang Y."
                                },
                                "@author-instance-id": "OB2BibRecID-947302102-de29ede3fd3703d0ca83a099a372dcb3-1",
                                "@seq": "11",
                                "ce:initials": "Y.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Wang",
                                "@auid": "57271603100",
                                "ce:indexed-name": "Wang Y."
                            },
                            {
                                "ce:given-name": "Khemaies",
                                "preferred-name": {
                                    "ce:given-name": "Khemaies",
                                    "ce:initials": "K.",
                                    "ce:surname": "Slimane",
                                    "ce:indexed-name": "Slimane K."
                                },
                                "@author-instance-id": "OB2BibRecID-947302102-82fca66b662e3586defa9050b86ad4eb-1",
                                "@seq": "13",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Slimane",
                                "@auid": "6603436777",
                                "ce:indexed-name": "Slimane K."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60009968",
                            "@country": "usa",
                            "city": "East Hanover",
                            "organization": {"$": "Novartis Pharmaceuticals Corporation"},
                            "affiliation-id": {"@afid": "60009968"},
                            "state": "NJ",
                            "@affiliation-instance-id": "OB2BibRecID-947302102-cfc9aac838ffa8e60369e0362e05001d-1",
                            "ce:source-text": "Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"
                        },
                        "author": [{
                            "ce:given-name": "Paramita",
                            "preferred-name": {
                                "ce:given-name": "Paramita",
                                "ce:initials": "P.",
                                "ce:surname": "Sen",
                                "ce:indexed-name": "Sen P."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-e6c8069f9f47793a299b2f4d113a3ed9-1",
                            "@seq": "12",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Sen",
                            "@auid": "55619668500",
                            "ce:indexed-name": "Sen P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60006314",
                            "@country": "tha",
                            "city": "Songkhla",
                            "organization": [
                                {"$": "Songklanagarind Hospital"},
                                {"$": "Prince of Songkla University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60006314"},
                                {"@afid": "60028394"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947302102-c0b84f0a7f592003df9ceb0bd1f550ea-1",
                            "ce:source-text": "Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Sarayut",
                            "preferred-name": {
                                "ce:given-name": "Sarayut",
                                "ce:initials": "S.",
                                "ce:surname": "Geater",
                                "ce:indexed-name": "Geater S."
                            },
                            "@author-instance-id": "OB2BibRecID-947302102-17c3414905ce2a600174da2cdece8cf1-1",
                            "@seq": "14",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Geater",
                            "@auid": "16636219700",
                            "ce:indexed-name": "Geater S."
                        }]
                    }
                ],
                "citation-title": "Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis",
                "abstracts": "© 2023by the Korean Cancer Association.Purpose Previous report from the ASCEND-8 trial showed consistent efficacy with less gastrointestinal (GI) toxicity in patients with anaplastic lymphoma kinase-rearranged (ALK+) advanced/metastatic non-small cell lung cancer (NSCLC) treated with ceritinib 450-mg with food compared with 750-mg fasted. In this subgroup analysis, we report outcomes in Asian patients of the ASCEND-8 trial. Materials and Methods Key efficacy endpoints were blinded independent review committee (BIRC)-assessed overall response rate (ORR) and duration of response (DOR) evaluated per Response Evaluation Criteria in Solid Tumors v1.1. Other efficacy endpoints were investigator-assessed ORR and DOR; BIRC- and investigator-assessed progression-free survival (PFS) and disease control rate; overall survival (OS). Safety was evaluated by frequency and severity of adverse events. Results At final data cutoff (6 March 2020), 198 treatment-naïve patients were included in efficacy analysis, of which 74 (37%) comprised the Asian subset; 450-mg fed (n=29), 600-mg fed (n=19), and 750-mg fasted (n=26). Baseline characteristics were mostly comparable across study arms. At baseline, more patients in 450-mg fed arm (44.8%) had brain metastases than in 750-mg fasted arm (26.9%). Per BIRC, patients in the 450-mg fed arm had a numerically higher ORR, 24-month DOR rate and 24-month PFS rate than the 750-mg fasted arm. The 36-month OS rate was 93.1% in 450-mg fed arm and 70.9% in 750-mg fasted arm. Any-grade GI toxicity occurred in 82.8% and 96.2% of patients in the 450-mg fed and 750-mg fasted arms, respectively. Conclusion Asian patients with ALK+ advanced/metastatic NSCLC treated with ceritinib 450-mg fed showed numerically higher efficacy and lower GI toxicity than 750-mg fasted patients.",
                "correspondence": {
                    "affiliation": {
                        "country": "South Korea",
                        "address-part": "50-1 Yonsei-ro, Seodaemun-gu",
                        "postal-code": "03722",
                        "@country": "kor",
                        "city": "Seoul",
                        "organization": [
                            {"$": "Division of Medical Oncology"},
                            {"$": "Department of Internal Medicine"},
                            {"$": "Yonsei Cancer Center"},
                            {"$": "Yonsei University College of Medicine"}
                        ],
                        "@affiliation-instance-id": "OB2BibRecID-947302102-2914b083863c69e2d0717623a557b80d-1",
                        "ce:source-text": "Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea"
                    },
                    "person": {
                        "ce:given-name": "Byoung Chul",
                        "@author-instance-id": "OB2BibRecID-947302102-90db576e75f11f496f708b0125cda6f9-1",
                        "ce:initials": "B.C.",
                        "ce:surname": "Cho",
                        "ce:indexed-name": "Cho B.C."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "ALK-activated",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "ALK-inhibitors",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Ceritinib",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Non-small-cell lung carcinoma",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Cancer Res. Treat.",
                    "website": {"ce:e-address": {
                        "$": "https://www.e-crt.org/journal/view.php?number=3374",
                        "@type": "email"
                    }},
                    "@country": "kor",
                    "translated-sourcetitle": {
                        "$": "Cancer Research and Treatment",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "20059256",
                            "@type": "electronic"
                        },
                        {
                            "$": "15982998",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "55",
                            "@issue": "1"
                        },
                        "pagerange": {
                            "@first": "83",
                            "@last": "93"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "Korean Cancer Association"},
                    "sourcetitle": "Cancer Research and Treatment",
                    "@srcid": "21100199848",
                    "publicationdate": {
                        "month": "01",
                        "year": "2023",
                        "date-text": "January 2023",
                        "day": "01"
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "15",
                                    "classification-description": "Chest Diseases, Thoracic Surgery and Tuberculosis"
                                },
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2730"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "9000-86-6"},
                                        {"$": "9014-30-6"}
                                    ],
                                    "enzyme-commission-number": "EC 2.6.1.2",
                                    "chemical-name": "alanine aminotransferase"
                                },
                                {
                                    "cas-registry-number": "166433-56-3",
                                    "chemical-name": "anaplastic lymphoma kinase"
                                },
                                {
                                    "cas-registry-number": "9000-97-9",
                                    "enzyme-commission-number": "EC 2.6.1.1",
                                    "chemical-name": "aspartate aminotransferase"
                                },
                                {
                                    "cas-registry-number": "1032900-25-6",
                                    "chemical-name": "ceritinib"
                                },
                                {
                                    "cas-registry-number": "85876-02-4",
                                    "enzyme-commission-number": "EC 2.3.2.2",
                                    "chemical-name": "gamma glutamyltransferase"
                                },
                                {
                                    "cas-registry-number": "80449-02-1",
                                    "enzyme-commission-number": [
                                        {"$": "EC 2.7.1.112"},
                                        {"$": "EC 2.7.10"}
                                    ],
                                    "chemical-name": "protein tyrosine kinase"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Anaplastic Lymphoma Kinase"},
                                {"chemical-name": "ceritinib"},
                                {"chemical-name": "Protein Kinase Inhibitors"},
                                {"chemical-name": "Receptor Protein-Tyrosine Kinases"}
                            ]
                        }
                    ]}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "25",
                    "@timestamp": "BST 08:56:35",
                    "@year": "2023",
                    "@month": "04"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2023689154",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "637637442",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "947302102",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230306651",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "35344649",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2023129896",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20230931181",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20231266261",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20239005047488",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85146364976",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85146364976",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "637637442",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "295800999",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.4143/crt.2021.1571"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "25",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007; 448: 561-6.",
                        "@reference-instance-id": "OB2BibRecID-947302102-f52a6018c82bce8f8e03e91fffd5013f-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34547638047",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "448"},
                                "pagerange": {
                                    "@first": "561",
                                    "@last": "566"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Soda",
                                        "ce:indexed-name": "Soda M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "YL",
                                        "@_fa": "true",
                                        "ce:surname": "Choi",
                                        "ce:indexed-name": "Choi YL"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Enomoto",
                                        "ce:indexed-name": "Enomoto M"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Takada",
                                        "ce:indexed-name": "Takada S"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Yamashita",
                                        "ce:indexed-name": "Yamashita Y"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Ishikawa",
                                        "ce:indexed-name": "Ishikawa S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nature"
                        },
                        "ce:source-text": "Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007; 448: 561-6."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014; 371:2167-77.",
                        "@reference-instance-id": "OB2BibRecID-947302102-66af7e2f7cfb2b8f71660e10f62c014b-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "First-line crizotinib versus chemotherapy in ALK-positive lung cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84918804764",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "371"},
                                "pagerange": {
                                    "@first": "2167",
                                    "@last": "2177"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BJ",
                                        "@_fa": "true",
                                        "ce:surname": "Solomon",
                                        "ce:indexed-name": "Solomon BJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "DW",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim DW"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "YL",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu YL"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Nakagawa",
                                        "ce:indexed-name": "Nakagawa K"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Mekhail",
                                        "ce:indexed-name": "Mekhail T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, et al. First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med. 2014; 371:2167-77."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Soria JC, Tan DS, Chiari R, Wu YL, Paz-Ares L, Wolf J, et al. First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study. Lancet. 2017; 389:917-29.",
                        "@reference-instance-id": "OB2BibRecID-947302102-ff55c22113963f6258cd5dfbe3aa94c6-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85010189205",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "389"},
                                "pagerange": {
                                    "@first": "917",
                                    "@last": "929"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JC",
                                        "@_fa": "true",
                                        "ce:surname": "Soria",
                                        "ce:indexed-name": "Soria JC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DS",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan DS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Chiari",
                                        "ce:indexed-name": "Chiari R"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "YL",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu YL"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Paz-Ares",
                                        "ce:indexed-name": "Paz-Ares L"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Wolf",
                                        "ce:indexed-name": "Wolf J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Soria JC, Tan DS, Chiari R, Wu YL, Paz-Ares L, Wolf J, et al. First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study. Lancet. 2017; 389:917-29."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "U.S. Food and Drug Administration. Xalkori prescribing information [Internet]. Silver Spring, MD: U.S. Food and Drug Administration; 2017 [cited 2021 Oct 15]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/ 202570s021lbl.pdf.",
                        "@reference-instance-id": "OB2BibRecID-947302102-bdcd4fe023fe5476502512d1f63aba3b-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85110108343",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Silver Spring, MD: U.S. Food and Drug Administration; [cited 2021 Oct 15]",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "U.S. Food and Drug Administration",
                                "ce:indexed-name": "U.S. Food and Drug Administration"
                            }},
                            "ref-sourcetitle": "Xalkori prescribing information [Internet]"
                        },
                        "ce:source-text": "U.S. Food and Drug Administration. Xalkori prescribing information [Internet]. Silver Spring, MD: U.S. Food and Drug Administration; 2017 [cited 2021 Oct 15]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/ 202570s021lbl.pdf."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "U.S. Food and Drug Administration. Zykadia prescribing information [Internet]. Silver Spring, MD: U.S. Food and Drug Administration; 2019 [cited 2021 Oct 15]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/ 211225s000lbl.pdf.",
                        "@reference-instance-id": "OB2BibRecID-947302102-e125974ac81eddbaef0bd50796a27e14-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211225s000lbl.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85135044707",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Silver Spring, MD: U.S. Food and Drug Administration; [cited 2021 Oct 15]",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "U.S. Food and Drug Administration",
                                "ce:indexed-name": "U.S. Food and Drug Administration"
                            }},
                            "ref-sourcetitle": "Zykadia prescribing information [Internet]"
                        },
                        "ce:source-text": "U.S. Food and Drug Administration. Zykadia prescribing information [Internet]. Silver Spring, MD: U.S. Food and Drug Administration; 2019 [cited 2021 Oct 15]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/ 211225s000lbl.pdf."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Gristina V, La Mantia M, Iacono F, Galvano A, Russo A, Bazan V. The emerging therapeutic landscape of ALK inhibitors in non-small cell lung cancer. Pharmaceuticals (Basel). 2020; 13:474.",
                        "@reference-instance-id": "OB2BibRecID-947302102-d797de057700df925df59d4dffe83e19-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The emerging therapeutic landscape of ALK inhibitors in non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85098213833",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {"@first": "474"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "V",
                                    "@_fa": "true",
                                    "ce:surname": "Gristina",
                                    "ce:indexed-name": "Gristina V"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "La Mantia",
                                    "ce:indexed-name": "La Mantia M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Iacono",
                                    "ce:indexed-name": "Iacono F"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Galvano",
                                    "ce:indexed-name": "Galvano A"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Russo",
                                    "ce:indexed-name": "Russo A"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Bazan",
                                    "ce:indexed-name": "Bazan V."
                                }
                            ]},
                            "ref-sourcetitle": "Pharmaceuticals (Basel)"
                        },
                        "ce:source-text": "Gristina V, La Mantia M, Iacono F, Galvano A, Russo A, Bazan V. The emerging therapeutic landscape of ALK inhibitors in non-small cell lung cancer. Pharmaceuticals (Basel). 2020; 13:474."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "U.S. Food and Drug Administration. FDA broadens ceritinib indication to previously untreated ALK-positive metastatic NSCLC [Internet]. Spring, MD: U.S. Food and Drug Administration; c2017 [cited 2021 May 8]. Available from: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-broadens-ceritinib-indication-previously-untreated-alk-positive-metastatic-NSCLC.",
                        "@reference-instance-id": "OB2BibRecID-947302102-5f68fc5d16be7774bc56fc4023567ba6-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.fda.gov/drugs/resources-information-approved-drugs/fda-broadens-ceritinib-indication-previously-untreated-alk-positive-metastatic-NSCLC",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85042801648",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Spring, MD: U.S. Food and Drug Administration; c2017 [cited 2021 May 8]",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "U.S. Food and Drug Administration",
                                "ce:indexed-name": "U.S. Food and Drug Administration"
                            }},
                            "ref-sourcetitle": "FDA broadens ceritinib indication to previously untreated ALK-positive metastatic NSCLC [Internet]"
                        },
                        "ce:source-text": "U.S. Food and Drug Administration. FDA broadens ceritinib indication to previously untreated ALK-positive metastatic NSCLC [Internet]. Spring, MD: U.S. Food and Drug Administration; c2017 [cited 2021 May 8]. Available from: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-broadens-ceritinib-indication-previously-untreated-alk-positive-metastatic-NSCLC."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Shaw AT, Kim TM, Crino L, Gridelli C, Kiura K, Liu G, et al. Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 2017; 18:874-86.",
                        "@reference-instance-id": "OB2BibRecID-947302102-34cfce01c3225ae4229dfa736faa7851-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85020421673",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "874",
                                    "@last": "886"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AT",
                                        "@_fa": "true",
                                        "ce:surname": "Shaw",
                                        "ce:indexed-name": "Shaw AT"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "TM",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim TM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Crino",
                                        "ce:indexed-name": "Crino L"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Gridelli",
                                        "ce:indexed-name": "Gridelli C"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Kiura",
                                        "ce:indexed-name": "Kiura K"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Shaw AT, Kim TM, Crino L, Gridelli C, Kiura K, Liu G, et al. Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 2017; 18:874-86."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Crino L, Ahn MJ, De Marinis F, Groen HJ, Wakelee H, Hida T, et al. Multicenter phase II study of whole-body and intracranial activity with ceritinib in patients with ALK-rearranged non-small-cell lung cancer previously treated with chemotherapy and crizotinib: results from ASCEND-2. J Clin Oncol. 2016; 34:2866-73.",
                        "@reference-instance-id": "OB2BibRecID-947302102-8593fa0a0a4dae9d1a1c8e301dc431ec-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Multicenter phase II study of whole-body and intracranial activity with ceritinib in patients with ALK-rearranged non-small-cell lung cancer previously treated with chemotherapy and crizotinib: results from ASCEND-2"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84982084050",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "2866",
                                    "@last": "2873"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Crino",
                                        "ce:indexed-name": "Crino L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "Ahn",
                                        "ce:indexed-name": "Ahn MJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "De Marinis",
                                        "ce:indexed-name": "De Marinis F"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "HJ",
                                        "@_fa": "true",
                                        "ce:surname": "Groen",
                                        "ce:indexed-name": "Groen HJ"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Wakelee",
                                        "ce:indexed-name": "Wakelee H"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Hida",
                                        "ce:indexed-name": "Hida T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Crino L, Ahn MJ, De Marinis F, Groen HJ, Wakelee H, Hida T, et al. Multicenter phase II study of whole-body and intracranial activity with ceritinib in patients with ALK-rearranged non-small-cell lung cancer previously treated with chemotherapy and crizotinib: results from ASCEND-2. J Clin Oncol. 2016; 34:2866-73."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Kim DW, Mehra R, Tan DSW, Felip E, Chow LQ, Camidge DR, et al. Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial. Lancet Oncol. 2016; 17:452-63.",
                        "@reference-instance-id": "OB2BibRecID-947302102-e814a5230ea3bc72dd728f5a5dd49905-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84960194194",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "452",
                                    "@last": "463"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DW",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim DW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Mehra",
                                        "ce:indexed-name": "Mehra R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "DSW",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan DSW"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Felip",
                                        "ce:indexed-name": "Felip E"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "LQ",
                                        "@_fa": "true",
                                        "ce:surname": "Chow",
                                        "ce:indexed-name": "Chow LQ"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "DR",
                                        "@_fa": "true",
                                        "ce:surname": "Camidge",
                                        "ce:indexed-name": "Camidge DR"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Kim DW, Mehra R, Tan DSW, Felip E, Chow LQ, Camidge DR, et al. Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial. Lancet Oncol. 2016; 17:452-63."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Cho BC, Kim DW, Bearz A, Laurie SA, McKeage M, Borra G, et al. ASCEND-8: a randomized phase 1 study of ceritinib, 450 mg or 600 mg, taken with a low-fat meal versus 750 mg in fasted state in patients with snaplastic lymphoma kinase (ALK)-rearranged metastatic non-small cell lung cancer (NSCLC). J Thorac Oncol. 2017; 12:1357-67.",
                        "@reference-instance-id": "OB2BibRecID-947302102-6aa4af705934aab1263802248774349c-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "ASCEND-8: a randomized phase 1 study of ceritinib, 450 mg or 600 mg, taken with a low-fat meal versus 750 mg in fasted state in patients with snaplastic lymphoma kinase (ALK)-rearranged metastatic non-small cell lung cancer (NSCLC)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85028315202",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "1357",
                                    "@last": "1367"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BC",
                                        "@_fa": "true",
                                        "ce:surname": "Cho",
                                        "ce:indexed-name": "Cho BC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DW",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim DW"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Bearz",
                                        "ce:indexed-name": "Bearz A"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "SA",
                                        "@_fa": "true",
                                        "ce:surname": "Laurie",
                                        "ce:indexed-name": "Laurie SA"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "McKeage",
                                        "ce:indexed-name": "McKeage M"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Borra",
                                        "ce:indexed-name": "Borra G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thorac Oncol"
                        },
                        "ce:source-text": "Cho BC, Kim DW, Bearz A, Laurie SA, McKeage M, Borra G, et al. ASCEND-8: a randomized phase 1 study of ceritinib, 450 mg or 600 mg, taken with a low-fat meal versus 750 mg in fasted state in patients with snaplastic lymphoma kinase (ALK)-rearranged metastatic non-small cell lung cancer (NSCLC). J Thorac Oncol. 2017; 12:1357-67."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Cho BC, Obermannova R, Bearz A, McKeage M, Kim DW, Batra U, et al. Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-positive NSCLC: primary efficacy results from the ASCEND-8 study. J Thorac Oncol. 2019; 14:1255-65.",
                        "@reference-instance-id": "OB2BibRecID-947302102-3bc9fcffd59d0117667c09118c67d9fe-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-positive NSCLC: primary efficacy results from the ASCEND-8 study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85064602235",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "1255",
                                    "@last": "1265"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BC",
                                        "@_fa": "true",
                                        "ce:surname": "Cho",
                                        "ce:indexed-name": "Cho BC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Obermannova",
                                        "ce:indexed-name": "Obermannova R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Bearz",
                                        "ce:indexed-name": "Bearz A"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "McKeage",
                                        "ce:indexed-name": "McKeage M"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "DW",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim DW"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "U",
                                        "@_fa": "true",
                                        "ce:surname": "Batra",
                                        "ce:indexed-name": "Batra U"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thorac Oncol"
                        },
                        "ce:source-text": "Cho BC, Obermannova R, Bearz A, McKeage M, Kim DW, Batra U, et al. Efficacy and safety of ceritinib (450 mg/d or 600 mg/d) with food versus 750-mg/d fasted in patients with ALK receptor tyrosine kinase (ALK)-positive NSCLC: primary efficacy results from the ASCEND-8 study. J Thorac Oncol. 2019; 14:1255-65."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Tan DS, Geater S, Yu CJ, Tsai CM, Hsia TC, Chen J, et al. Ceri-tinib efficacy and safety in treatment-naive Asian patients with advanced ALK-rearranged NSCLC: an ASCEND-4 subgroup analysis. JTO Clin Res Rep. 2021; 2:100131.",
                        "@reference-instance-id": "OB2BibRecID-947302102-5edcb9c8223dfd1ba7d96a1a189b155f-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Ceri-tinib efficacy and safety in treatment-naive Asian patients with advanced ALK-rearranged NSCLC: an ASCEND-4 subgroup analysis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85109827725",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {"@first": "100131"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DS",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan DS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Geater",
                                        "ce:indexed-name": "Geater S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "CJ",
                                        "@_fa": "true",
                                        "ce:surname": "Yu",
                                        "ce:indexed-name": "Yu CJ"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "CM",
                                        "@_fa": "true",
                                        "ce:surname": "Tsai",
                                        "ce:indexed-name": "Tsai CM"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "TC",
                                        "@_fa": "true",
                                        "ce:surname": "Hsia",
                                        "ce:indexed-name": "Hsia TC"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JTO Clin Res Rep"
                        },
                        "ce:source-text": "Tan DS, Geater S, Yu CJ, Tsai CM, Hsia TC, Chen J, et al. Ceri-tinib efficacy and safety in treatment-naive Asian patients with advanced ALK-rearranged NSCLC: an ASCEND-4 subgroup analysis. JTO Clin Res Rep. 2021; 2:100131."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Zhou C, Kim SW, Reungwetwattana T, Zhou J, Zhang Y, He J, et al. Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study. Lancet Respir Med. 2019; 7:437-46.",
                        "@reference-instance-id": "OB2BibRecID-947302102-d63d1b20cae4d0441655ec4854abe9dd-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85064705621",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "437",
                                    "@last": "446"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SW",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim SW"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Reungwetwattana",
                                        "ce:indexed-name": "Reungwetwattana T"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou J"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang Y"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "He",
                                        "ce:indexed-name": "He J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Respir Med"
                        },
                        "ce:source-text": "Zhou C, Kim SW, Reungwetwattana T, Zhou J, Zhang Y, He J, et al. Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study. Lancet Respir Med. 2019; 7:437-46."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Mok TS, Peters S, Camidge DR, Ou SH, Ahn JS, Tan EH, et al. Alectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study. Ann Oncol. 2017; 28(Suppl 10):X191.",
                        "@reference-instance-id": "OB2BibRecID-947302102-e9c5bba1a9413801c42ab4f3cc3b3a95-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Alectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85054844856",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {"@first": "X191"}
                            },
                            "ref-text": "(Suppl 10)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "TS",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok TS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Peters",
                                        "ce:indexed-name": "Peters S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "DR",
                                        "@_fa": "true",
                                        "ce:surname": "Camidge",
                                        "ce:indexed-name": "Camidge DR"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "SH",
                                        "@_fa": "true",
                                        "ce:surname": "Ou",
                                        "ce:indexed-name": "Ou SH"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "JS",
                                        "@_fa": "true",
                                        "ce:surname": "Ahn",
                                        "ce:indexed-name": "Ahn JS"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "EH",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan EH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Mok TS, Peters S, Camidge DR, Ou SH, Ahn JS, Tan EH, et al. Alectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study. Ann Oncol. 2017; 28(Suppl 10):X191."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Nishio M, Kim DW, Wu YL, Nakagawa K, Solomon BJ, Shaw AT, et al. Crizotinib versus chemotherapy in Asian patients with ALK-positive advanced non-small cell lung cancer. Cancer Res Treat. 2018; 50:691-700.",
                        "@reference-instance-id": "OB2BibRecID-947302102-508ecc5f10b1fc8289f0fc8786fd098e-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Crizotinib versus chemotherapy in Asian patients with ALK-positive advanced non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85049774750",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "50"},
                                "pagerange": {
                                    "@first": "691",
                                    "@last": "700"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Nishio",
                                        "ce:indexed-name": "Nishio M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DW",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim DW"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "YL",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu YL"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Nakagawa",
                                        "ce:indexed-name": "Nakagawa K"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "BJ",
                                        "@_fa": "true",
                                        "ce:surname": "Solomon",
                                        "ce:indexed-name": "Solomon BJ"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "AT",
                                        "@_fa": "true",
                                        "ce:surname": "Shaw",
                                        "ce:indexed-name": "Shaw AT"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res Treat"
                        },
                        "ce:source-text": "Nishio M, Kim DW, Wu YL, Nakagawa K, Solomon BJ, Shaw AT, et al. Crizotinib versus chemotherapy in Asian patients with ALK-positive advanced non-small cell lung cancer. Cancer Res Treat. 2018; 50:691-700."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Wu YL, Lu S, Lu Y, Zhou J, Shi YK, Sriuranpong V, et al. Results of PROFILE 1029, a phase III comparison of first-line crizotinib versus chemotherapy in East Asian patients with ALK-positive advanced non-small cell lung cancer. J Thorac Oncol. 2018; 13:1539-48.",
                        "@reference-instance-id": "OB2BibRecID-947302102-3f02e077fe324892e2c64c5ff3b763b7-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Results of PROFILE 1029, a phase III comparison of first-line crizotinib versus chemotherapy in East Asian patients with ALK-positive advanced non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85051792172",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "1539",
                                    "@last": "1548"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "YL",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu YL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Lu",
                                        "ce:indexed-name": "Lu Y"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou J"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "YK",
                                        "@_fa": "true",
                                        "ce:surname": "Shi",
                                        "ce:indexed-name": "Shi YK"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Sriuranpong",
                                        "ce:indexed-name": "Sriuranpong V"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thorac Oncol"
                        },
                        "ce:source-text": "Wu YL, Lu S, Lu Y, Zhou J, Shi YK, Sriuranpong V, et al. Results of PROFILE 1029, a phase III comparison of first-line crizotinib versus chemotherapy in East Asian patients with ALK-positive advanced non-small cell lung cancer. J Thorac Oncol. 2018; 13:1539-48."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Mok T, Camidge DR, Gadgeel SM, Rosell R, Dziadziuszko R, Kim DW, et al. Updated overall survival and final progresReferences sion-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study. Ann Oncol. 2020; 31:1056-64.",
                        "@reference-instance-id": "OB2BibRecID-947302102-270cae77652d081a5e344b2a69f41f5a-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Updated overall survival and final progresReferences sion-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85087025913",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "1056",
                                    "@last": "1064"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DR",
                                        "@_fa": "true",
                                        "ce:surname": "Camidge",
                                        "ce:indexed-name": "Camidge DR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SM",
                                        "@_fa": "true",
                                        "ce:surname": "Gadgeel",
                                        "ce:indexed-name": "Gadgeel SM"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Rosell",
                                        "ce:indexed-name": "Rosell R"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Dziadziuszko",
                                        "ce:indexed-name": "Dziadziuszko R"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "DW",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim DW"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Mok T, Camidge DR, Gadgeel SM, Rosell R, Dziadziuszko R, Kim DW, et al. Updated overall survival and final progresReferences sion-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study. Ann Oncol. 2020; 31:1056-64."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Li H, Lai L, Wu B. Cost effectiveness of ceritinib and alectinib versus crizotinib in first-line anaplastic lymphoma kinasepositive advanced non-small-cell lung cancer. Clin Drug Investig. 2020; 40:183-9.",
                        "@reference-instance-id": "OB2BibRecID-947302102-945984931eeb1b73f086eabdefc092b1-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Cost effectiveness of ceritinib and alectinib versus crizotinib in first-line anaplastic lymphoma kinasepositive advanced non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85076840734",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {
                                    "@first": "183",
                                    "@last": "189"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li H"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Lai",
                                    "ce:indexed-name": "Lai L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Wu",
                                    "ce:indexed-name": "Wu B."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Drug Investig"
                        },
                        "ce:source-text": "Li H, Lai L, Wu B. Cost effectiveness of ceritinib and alectinib versus crizotinib in first-line anaplastic lymphoma kinasepositive advanced non-small-cell lung cancer. Clin Drug Investig. 2020; 40:183-9."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Gainor JF, Ou SH, Logan J, Borges LF, Shaw AT. The central nervous system as a sanctuary site in ALK-positive nonsmall-cell lung cancer. J Thorac Oncol. 2013; 8:1570-3.",
                        "@reference-instance-id": "OB2BibRecID-947302102-019fd254b8c6ea99f5e377b3761c8f16-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "The central nervous system as a sanctuary site in ALK-positive nonsmall-cell lung cancer"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84892187259",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "1570",
                                    "@last": "1573"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JF",
                                    "@_fa": "true",
                                    "ce:surname": "Gainor",
                                    "ce:indexed-name": "Gainor JF"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "SH",
                                    "@_fa": "true",
                                    "ce:surname": "Ou",
                                    "ce:indexed-name": "Ou SH"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Logan",
                                    "ce:indexed-name": "Logan J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "LF",
                                    "@_fa": "true",
                                    "ce:surname": "Borges",
                                    "ce:indexed-name": "Borges LF"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "AT.",
                                    "@_fa": "true",
                                    "ce:surname": "Shaw",
                                    "ce:indexed-name": "Shaw AT."
                                }
                            ]},
                            "ref-sourcetitle": "J Thorac Oncol"
                        },
                        "ce:source-text": "Gainor JF, Ou SH, Logan J, Borges LF, Shaw AT. The central nervous system as a sanctuary site in ALK-positive nonsmall-cell lung cancer. J Thorac Oncol. 2013; 8:1570-3."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Ali A, Goffin JR, Arnold A, Ellis PM. Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases. Curr Oncol. 2013; 20:e300-6.",
                        "@reference-instance-id": "OB2BibRecID-947302102-0c1c905ab48a928c8906032c49f190b5-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84881236515",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "e300",
                                    "@last": "e306"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Ali",
                                    "ce:indexed-name": "Ali A"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JR",
                                    "@_fa": "true",
                                    "ce:surname": "Goffin",
                                    "ce:indexed-name": "Goffin JR"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Arnold",
                                    "ce:indexed-name": "Arnold A"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "PM.",
                                    "@_fa": "true",
                                    "ce:surname": "Ellis",
                                    "ce:indexed-name": "Ellis PM."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Oncol"
                        },
                        "ce:source-text": "Ali A, Goffin JR, Arnold A, Ellis PM. Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases. Curr Oncol. 2013; 20:e300-6."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Gaspar LE, Chansky K, Albain KS, Vallieres E, Rusch V, Crowley JJ, et al. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol. 2005; 23:2955-61.",
                        "@reference-instance-id": "OB2BibRecID-947302102-8e1769eb9f52d50ed30647aa0ccdf431-22",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group"},
                            "refd-itemidlist": {"itemid": {
                                "$": "19444370034",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "2955",
                                    "@last": "2961"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "LE",
                                        "@_fa": "true",
                                        "ce:surname": "Gaspar",
                                        "ce:indexed-name": "Gaspar LE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Chansky",
                                        "ce:indexed-name": "Chansky K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "KS",
                                        "@_fa": "true",
                                        "ce:surname": "Albain",
                                        "ce:indexed-name": "Albain KS"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Vallieres",
                                        "ce:indexed-name": "Vallieres E"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Rusch",
                                        "ce:indexed-name": "Rusch V"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "JJ",
                                        "@_fa": "true",
                                        "ce:surname": "Crowley",
                                        "ce:indexed-name": "Crowley JJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Gaspar LE, Chansky K, Albain KS, Vallieres E, Rusch V, Crowley JJ, et al. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol. 2005; 23:2955-61."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Lee SJ, Lee JI, Nam DH, Ahn YC, Han JH, Sun JM, et al. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors. J Thorac Oncol. 2013; 8:185-91.",
                        "@reference-instance-id": "OB2BibRecID-947302102-d1e205f006a0940b74783d3552cac9c6-23",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84873861611",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "185",
                                    "@last": "191"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SJ",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee SJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JI",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee JI"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "DH",
                                        "@_fa": "true",
                                        "ce:surname": "Nam",
                                        "ce:indexed-name": "Nam DH"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "YC",
                                        "@_fa": "true",
                                        "ce:surname": "Ahn",
                                        "ce:indexed-name": "Ahn YC"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "JH",
                                        "@_fa": "true",
                                        "ce:surname": "Han",
                                        "ce:indexed-name": "Han JH"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "JM",
                                        "@_fa": "true",
                                        "ce:surname": "Sun",
                                        "ce:indexed-name": "Sun JM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thorac Oncol"
                        },
                        "ce:source-text": "Lee SJ, Lee JI, Nam DH, Ahn YC, Han JH, Sun JM, et al. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors. J Thorac Oncol. 2013; 8:185-91."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012; 30:419-25.",
                        "@reference-instance-id": "OB2BibRecID-947302102-d771f8aa0d5c8e387e83a949fb79be78-24",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84863020427",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "419",
                                    "@last": "425"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PW",
                                        "@_fa": "true",
                                        "ce:surname": "Sperduto",
                                        "ce:indexed-name": "Sperduto PW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Kased",
                                        "ce:indexed-name": "Kased N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Roberge",
                                        "ce:indexed-name": "Roberge D"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu Z"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Shanley",
                                        "ce:indexed-name": "Shanley R"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "X",
                                        "@_fa": "true",
                                        "ce:surname": "Luo",
                                        "ce:indexed-name": "Luo X"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012; 30:419-25."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v2.0.229",
                        "ref-fulltext": "Chow LQ, Barlesi F, Bertino EM, van den Bent MJ, Wakelee H, Wen PY, et al. Results of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain. Ann Oncol. 2019; 30(Suppl 5):v602-60.",
                        "@reference-instance-id": "OB2BibRecID-947302102-198f76eae630d5ab302cbf6536eb4adb-25",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Results of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85076220317",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "v602",
                                    "@last": "v660"
                                }
                            },
                            "ref-text": "(Suppl 5)",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "LQ",
                                        "@_fa": "true",
                                        "ce:surname": "Chow",
                                        "ce:indexed-name": "Chow LQ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Barlesi",
                                        "ce:indexed-name": "Barlesi F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "EM",
                                        "@_fa": "true",
                                        "ce:surname": "Bertino",
                                        "ce:indexed-name": "Bertino EM"
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "van den Bent",
                                        "ce:indexed-name": "van den Bent MJ"
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Wakelee",
                                        "ce:indexed-name": "Wakelee H"
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "PY",
                                        "@_fa": "true",
                                        "ce:surname": "Wen",
                                        "ce:indexed-name": "Wen PY"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Chow LQ, Barlesi F, Bertino EM, van den Bent MJ, Wakelee H, Wen PY, et al. Results of the ASCEND-7 phase II study evaluating ALK inhibitor (ALKi) ceritinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) metastatic to the brain. Ann Oncol. 2019; 30(Suppl 5):v602-60."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Basel",
            "@id": "60009968",
            "affilname": "Novartis International AG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60115402",
            "affilname": "Yonsei Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60115402",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Kuching",
            "@id": "60090650",
            "affilname": "Hospital Umum Sarawak",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090650",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "New Delhi",
            "@id": "60070271",
            "affilname": "Rajiv Gandhi Cancer Institute and Research Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60070271",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60068691",
            "affilname": "Asan Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068691",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60021119",
            "affilname": "Seoul National University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021119",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60020857",
            "affilname": "Samsung Medical Center, Sungkyunkwan university",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020857",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Taoyuan",
            "@id": "60020351",
            "affilname": "Chang Gung University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020351",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bengaluru",
            "@id": "60003789",
            "affilname": "Kidwai Memorial Institute of Oncology India",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003789",
            "affiliation-country": "India"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85146364976",
        "dc:description": "Purpose Previous report from the ASCEND-8 trial showed consistent efficacy with less gastrointestinal (GI) toxicity in patients with anaplastic lymphoma kinase-rearranged (ALK+) advanced/metastatic non-small cell lung cancer (NSCLC) treated with ceritinib 450-mg with food compared with 750-mg fasted. In this subgroup analysis, we report outcomes in Asian patients of the ASCEND-8 trial. Materials and Methods Key efficacy endpoints were blinded independent review committee (BIRC)-assessed overall response rate (ORR) and duration of response (DOR) evaluated per Response Evaluation Criteria in Solid Tumors v1.1. Other efficacy endpoints were investigator-assessed ORR and DOR; BIRC- and investigator-assessed progression-free survival (PFS) and disease control rate; overall survival (OS). Safety was evaluated by frequency and severity of adverse events. Results At final data cutoff (6 March 2020), 198 treatment-naïve patients were included in efficacy analysis, of which 74 (37%) comprised the Asian subset; 450-mg fed (n=29), 600-mg fed (n=19), and 750-mg fasted (n=26). Baseline characteristics were mostly comparable across study arms. At baseline, more patients in 450-mg fed arm (44.8%) had brain metastases than in 750-mg fasted arm (26.9%). Per BIRC, patients in the 450-mg fed arm had a numerically higher ORR, 24-month DOR rate and 24-month PFS rate than the 750-mg fasted arm. The 36-month OS rate was 93.1% in 450-mg fed arm and 70.9% in 750-mg fasted arm. Any-grade GI toxicity occurred in 82.8% and 96.2% of patients in the 450-mg fed and 750-mg fasted arms, respectively. Conclusion Asian patients with ALK+ advanced/metastatic NSCLC treated with ceritinib 450-mg fed showed numerically higher efficacy and lower GI toxicity than 750-mg fasted patients.",
        "pubmed-id": "35344649",
        "prism:coverDate": "2023-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85146364976",
        "dc:creator": {"author": [{
            "ce:given-name": "Byoung Chul",
            "preferred-name": {
                "ce:given-name": "Byoung Chul",
                "ce:initials": "B.C.",
                "ce:surname": "Cho",
                "ce:indexed-name": "Cho B.C."
            },
            "@seq": "1",
            "ce:initials": "B.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60115402",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60115402"
            },
            "ce:surname": "Cho",
            "@auid": "57211677252",
            "author-url": "https://api.elsevier.com/content/author/author_id/57211677252",
            "ce:indexed-name": "Cho B.C."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85146364976"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85146364976&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85146364976&origin=inward"
            }
        ],
        "source-id": "21100199848",
        "citedby-count": "0",
        "prism:volume": "55",
        "subtype": "ar",
        "dc:title": "Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis",
        "openaccess": "1",
        "prism:issn": "20059256 15982998",
        "publishercopyright": "© 2023by the Korean Cancer Association.",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "Cancer Research and Treatment",
        "prism:pageRange": "83-93",
        "prism:endingPage": "93",
        "openaccessFlag": "true",
        "prism:doi": "10.4143/crt.2021.1571",
        "prism:startingPage": "83",
        "dc:identifier": "SCOPUS_ID:85146364976",
        "dc:publisher": "Korean Cancer Association"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Anaplastic Lymphoma Kinase",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Carcinoma, Non-Small-Cell Lung",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Lung Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Protein Kinase Inhibitors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Receptor Protein-Tyrosine Kinases",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "ALK-activated"
        },
        {
            "@_fa": "true",
            "$": "ALK-inhibitors"
        },
        {
            "@_fa": "true",
            "$": "Ceritinib"
        },
        {
            "@_fa": "true",
            "$": "Non-small-cell lung carcinoma"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Byoung Chul",
            "preferred-name": {
                "ce:given-name": "Byoung Chul",
                "ce:initials": "B.C.",
                "ce:surname": "Cho",
                "ce:indexed-name": "Cho B.C."
            },
            "@seq": "1",
            "ce:initials": "B.C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60115402",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60115402"
            },
            "ce:surname": "Cho",
            "@auid": "57211677252",
            "author-url": "https://api.elsevier.com/content/author/author_id/57211677252",
            "ce:indexed-name": "Cho B.C."
        },
        {
            "ce:given-name": "Dong-Wan",
            "preferred-name": {
                "ce:given-name": "Dong Wan",
                "ce:initials": "D.W.",
                "ce:surname": "Kim",
                "ce:indexed-name": "Kim D.W."
            },
            "@seq": "2",
            "ce:initials": "D.-W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60021119",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021119"
            },
            "ce:surname": "Kim",
            "@auid": "56189698600",
            "author-url": "https://api.elsevier.com/content/author/author_id/56189698600",
            "ce:indexed-name": "Kim D.-W."
        },
        {
            "ce:given-name": "Ullas",
            "preferred-name": {
                "ce:given-name": "Ullas",
                "ce:initials": "U.",
                "ce:surname": "Batra",
                "ce:indexed-name": "Batra U."
            },
            "@seq": "3",
            "ce:initials": "U.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60070271",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60070271"
            },
            "ce:surname": "Batra",
            "@auid": "15924728800",
            "author-url": "https://api.elsevier.com/content/author/author_id/15924728800",
            "ce:indexed-name": "Batra U."
        },
        {
            "ce:given-name": "Keunchil",
            "preferred-name": {
                "ce:given-name": "Keunchil",
                "ce:initials": "K.",
                "ce:surname": "Park",
                "ce:indexed-name": "Park K."
            },
            "@seq": "4",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60020857",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020857"
            },
            "ce:surname": "Park",
            "@auid": "7408064384",
            "author-url": "https://api.elsevier.com/content/author/author_id/7408064384",
            "ce:indexed-name": "Park K."
        },
        {
            "ce:given-name": "Sang-We",
            "preferred-name": {
                "ce:given-name": "Sang We",
                "ce:initials": "S.W.",
                "ce:surname": "Kim",
                "ce:indexed-name": "Kim S.W."
            },
            "@seq": "5",
            "ce:initials": "S.-W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60068691",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068691"
            },
            "ce:surname": "Kim",
            "@auid": "57939462700",
            "author-url": "https://api.elsevier.com/content/author/author_id/57939462700",
            "ce:indexed-name": "Kim S.-W."
        },
        {
            "ce:given-name": "Cheng-Ta",
            "preferred-name": {
                "ce:given-name": "Cheng Ta",
                "ce:initials": "C.T.",
                "ce:surname": "Yang",
                "ce:indexed-name": "Yang C.T."
            },
            "@seq": "6",
            "ce:initials": "C.-T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60020351",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020351"
            },
            "ce:surname": "Yang",
            "@auid": "8201458000",
            "author-url": "https://api.elsevier.com/content/author/author_id/8201458000",
            "ce:indexed-name": "Yang C.-T."
        },
        {
            "ce:given-name": "Pei-Jye",
            "preferred-name": {
                "ce:given-name": "Pei Jye",
                "ce:initials": "P.J.",
                "ce:surname": "Voon",
                "ce:indexed-name": "Voon P.J."
            },
            "@seq": "7",
            "ce:initials": "P.-J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60090650",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60090650"
            },
            "ce:surname": "Voon",
            "@auid": "50462645100",
            "author-url": "https://api.elsevier.com/content/author/author_id/50462645100",
            "ce:indexed-name": "Voon P.-J."
        },
        {
            "ce:given-name": "Virote",
            "preferred-name": {
                "ce:given-name": "Virote",
                "ce:initials": "V.",
                "ce:surname": "Sriuranpong",
                "ce:indexed-name": "Sriuranpong V."
            },
            "@seq": "8",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:surname": "Sriuranpong",
            "@auid": "6603599644",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603599644",
            "ce:indexed-name": "Sriuranpong V."
        },
        {
            "ce:given-name": "K. Govind",
            "preferred-name": {
                "ce:given-name": "K. Govind",
                "ce:initials": "K.G.",
                "ce:surname": "Babu",
                "ce:indexed-name": "Babu K.G."
            },
            "@seq": "9",
            "ce:initials": "K.G.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60003789",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003789"
            },
            "ce:surname": "Babu",
            "@auid": "7102427411",
            "author-url": "https://api.elsevier.com/content/author/author_id/7102427411",
            "ce:indexed-name": "Babu K.G."
        },
        {
            "ce:given-name": "Khalid",
            "preferred-name": {
                "ce:given-name": "Khalid",
                "ce:initials": "K.",
                "ce:surname": "Amin",
                "ce:indexed-name": "Amin K."
            },
            "@seq": "10",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009968",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968"
            },
            "ce:surname": "Amin",
            "@auid": "58067491900",
            "author-url": "https://api.elsevier.com/content/author/author_id/58067491900",
            "ce:indexed-name": "Amin K."
        },
        {
            "ce:given-name": "Yingbo",
            "preferred-name": {
                "ce:given-name": "Yingbo",
                "ce:initials": "Y.",
                "ce:surname": "Wang",
                "ce:indexed-name": "Wang Y."
            },
            "@seq": "11",
            "ce:initials": "Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009968",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968"
            },
            "ce:surname": "Wang",
            "@auid": "57271603100",
            "author-url": "https://api.elsevier.com/content/author/author_id/57271603100",
            "ce:indexed-name": "Wang Y."
        },
        {
            "ce:given-name": "Paramita",
            "preferred-name": {
                "ce:given-name": "Paramita",
                "ce:initials": "P.",
                "ce:surname": "Sen",
                "ce:indexed-name": "Sen P."
            },
            "@seq": "12",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009968",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968"
            },
            "ce:surname": "Sen",
            "@auid": "55619668500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55619668500",
            "ce:indexed-name": "Sen P."
        },
        {
            "ce:given-name": "Khemaies",
            "preferred-name": {
                "ce:given-name": "Khemaies",
                "ce:initials": "K.",
                "ce:surname": "Slimane",
                "ce:indexed-name": "Slimane K."
            },
            "@seq": "13",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009968",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009968"
            },
            "ce:surname": "Slimane",
            "@auid": "6603436777",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603436777",
            "ce:indexed-name": "Slimane K."
        },
        {
            "ce:given-name": "Sarayut",
            "preferred-name": {
                "ce:given-name": "Sarayut",
                "ce:initials": "S.",
                "ce:surname": "Geater",
                "ce:indexed-name": "Geater S."
            },
            "@seq": "14",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006314",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314"
            },
            "ce:surname": "Geater",
            "@auid": "16636219700",
            "author-url": "https://api.elsevier.com/content/author/author_id/16636219700",
            "ce:indexed-name": "Geater S."
        }
    ]}
}}